Auris Medical Holding AG (NASDAQ:EARS) announced that its CEO, Thomas Meyer, is scheduled to present at an investor event in New York next week. The company is currently involved in a multilayer study of a treatment for inner ear disorders. Enrollment is ongoing for the Phase 3 trial of its lead drug candidate…